ICON PLC (ICLR) Stock Analysis

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NASDAQ

Key Metrics

• Price: $106.13
• Market Cap: $7.85B
• P/E Ratio: 14.03
• EPS: $7.20
• 52-Week High: $211.00
• 52-Week Low: $66.57

Market Sentiment

ICON PLC currently has a Neutral sentiment score of -0.02.

About ICON PLC

ICON Public Limited Company is a premier global clinical research organization (CRO) based in Dublin, Ireland, dedicated to delivering comprehensive outsourced development and commercialization services to the pharmaceutical, biotechnology, and medical device sectors. With a robust operational footprint across Europe, the United States, and other key markets, ICON excels in optimizing clinical trials, regulatory compliance, and market access strategies, enhancing client efficiencies in drug d...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for ICON PLC and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does ICLR pay dividends?

ICON PLC (ICLR) does not currently pay a regular dividend.

What is ICLR's P/E ratio?

ICON PLC has a price-to-earnings (P/E) ratio of 14.03.

What is ICLR's market cap?

ICON PLC (ICLR) has a market capitalization of $7.85B with a current stock price of $106.13.